|

Telitacicept Clinical Trials

6 actively recruiting trials across 1 location

Also known as: RC-18, RC18, RC18-L

Other5 trials

A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)
Phase 3
A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus
Phase 1
Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus
Phase 3
Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients
N/A
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Phase 2

Los Angeles, California1 trial

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (RemeMG)

University of Southern California

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.